IL-37 is an anti-inflammatory modulator in obesity and attenuates inflammation via the activation of AMPK signaling, decreased secretion of pro-inflammatory cytokines, decreased recruitment of pro-inflammatory cells, and attenuating the downstream pro-inflammatory signaling through TLRs in mice [46]. Here, IL37 is linked to obesity disorder.